RSPO2 and hepatocellular carcinoma: Several other studies reported subsets of hepatocellular carcinoma that harbor RSPO2 copy number amplifications or enhanced RSPO2 mRNA expression associated with Wnt/β-catenin activation [136, 138, 139].